Seoul Pharma Co., Ltd (KOSDAQ:018680)

Seoul Pharma Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 12, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	33,346	38,592	44,655	58,646	66,918	93,344
Market Cap Growth	-18.17%	-13.58%	-23.86%	-12.36%	-28.31%	62.97%
Enterprise Value	43,528	44,514	45,715	75,292	82,364	102,200
Last Close Price	2860.00	3310.00	3830.00	5030.00	7850.00	10950.00
PE Ratio	18.63	22.72	12.70	68.58	-	-
PS Ratio	0.64	0.72	0.85	1.17	1.65	1.79
PB Ratio	0.81	0.96	1.16	1.66	3.53	3.24
P/TBV Ratio	0.82	0.98	1.18	1.70	3.70	3.36
P/FCF Ratio	-	-	13.24	-	-	17.66
P/OCF Ratio	-	-	8.48	-	-	16.27
EV/Sales Ratio	0.83	0.83	0.87	1.50	2.04	1.96
EV/EBITDA Ratio	19.44	11.08	14.56	17.30	-	11.95
EV/EBIT Ratio	-	29.14	37.70	43.30	-	16.72
EV/FCF Ratio	-9.63	-	13.56	-	-	19.34
Debt / Equity Ratio	0.43	0.40	0.28	0.42	1.55	0.94
Debt / EBITDA Ratio	7.92	4.01	3.49	3.43	-	3.17
Debt / FCF Ratio	-	-	3.25	-	-	5.14
Net Debt / Equity Ratio	0.25	0.21	0.03	0.09	0.82	0.42
Net Debt / EBITDA Ratio	4.55	2.14	0.41	0.74	-4.89	1.41
Net Debt / FCF Ratio	-2.25	-1.64	0.38	-2.45	-5.50	2.29
Asset Turnover	0.74	0.79	0.83	0.80	0.64	0.77
Inventory Turnover	1.63	1.81	2.10	2.29	2.15	2.02
Quick Ratio	1.11	1.20	0.72	1.20	0.64	0.99
Current Ratio	2.17	2.28	1.25	1.87	0.86	1.41
Return on Equity (ROE)	4.43%	4.32%	9.51%	3.15%	-40.53%	-4.68%
Return on Assets (ROA)	-0.38%	1.42%	1.21%	1.74%	-5.61%	5.62%
Return on Invested Capital (ROIC)	-0.84%	3.33%	2.69%	4.75%	-15.14%	13.85%
Return on Capital Employed (ROCE)	-0.80%	2.70%	2.80%	3.60%	-17.10%	13.10%
Earnings Yield	5.37%	4.40%	7.88%	1.46%	-14.48%	-1.44%
FCF Yield	-13.56%	-13.57%	7.55%	-2.24%	-4.23%	5.66%
Buyback Yield / Dilution	-	-	-29.84%	-5.34%	-0.31%	-0.15%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.